![]() ![]() For six other priority conditions, gene therapy or enzyme replacement therapy is needed that are still under patent. Six of these conditions have been termed as “low hanging fruits” with their treatment dependent on easily manufactured small molecule medicines that are already out of patent. In addition, the government is looking at whether making it available at Jan Aushadhi stores will be feasible, the official said. The medicines, at present, are available at the centres of excellence for rare diseases. With patients of rare diseases living in disparate regions in the country, the government is also looking at ways to ensure that the medicines become available to them. The government is working with the drug companies to ensure availability of cheaper, indigenously manufactured therapies for at least 13 priority conditions that are commoner, have existing therapies or science is at an advanced stage, and for which a therapy could drastically change the quality of life. Around 6% to 8% of the population is estimated to have a rare disease, meaning 8.4 crore to 10 crore Indians are living with these conditions for which treatments either do not exist or therapies are extremely expensive. A condition is considered to be a rare disease if its prevalence is less than one case per 1,000 population. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |